VERO venusconcept.com Profit After Tax

Corporate emblem and logo of venusconcept.com (VERO)

High demand cyclicity for beauty devices during crises combines with inertial sales, which, amid rising debts, lead to cash flow stagnation for Venus Concept Inc. (VERO). The organization's net income level helps identify hidden business vulnerabilities, and 0.00 reflects the latest metric level. Meanwhile, trade conflicts and falling household incomes driven by geopolitics are undermining Asian supplies and demand.

Net Income: Venus Concept Corp (VERO) for 07/04/2022 - 02/21/2026

Financial and market metric breakdowns for Venus Concept (VERO)

- market value and analyst target forecast:
Stock Price Venus Concept Corporation|VERO - Price Target Chart
- market capitalization data:
Market Valuation Venus Concept Corporation|VERO - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Venus Concept|VERO - Company Net Assets|Market Capitalization to Book Value Ratio venusconcept.com|VERO - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital Venus Concept Inc.|VERO - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Venus Concept Inc|VERO - Company Aggregate Debts|Debt to Book Value Venus Concept Corporation|VERO - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Venus Concept|Quick Liquidity Indicator venusconcept.com
- company profitability and valuation multiples indicators:
VERO - Net Profit
Fundamental valuation:VERO, Venus Concept Corporation
Flagship merchandise of Venus Concept Corp

Daily operating profit serves as a mathematical measure of real business efficiency, eliminating time lags and objectively reflecting the issuer's current state through the probability distribution of future earnings. By analyzing this indicator of financial success, an investor assesses the export stability of Venus Concept Inc. (VERO), where the optimization of global logistics chains and spare parts warehouses converts directly into the maintenance of operating profitability.

Key competitors

Dexcom CGM (DXCM) - Net Profit|Company Net Income Penumbra, Inc.|novanta.com - Profit After Tax|Net Profit HAE|INSP - Company Net Income|PROCEPT BioRobotics Inc - Net Income|Net Profit CONMED Inc. CNMD|PLSE: Net Income|inmodemd.com - Profit After Payment of Taxes|PMI: Net Profit|SRDX - Net Financial Result|SENS (Senseonics Holdings) - Net Profit|Net Income NeuroPace Medical (NPCE)|Net Income TCMD (Tactile Systems Technology)|SNWV (sanuwave.com) - Final Profit|Company Net Income Outset Medical OM|ELMD - Net Income|LENSAR, Inc - Net Profit|Company Net Income AVITA Medical Inc|PROF: Net Profit|Company Profit BDMD|EDAP (EDAP TMS SA) - Net Profit|Bovie Medical (APYX) - Net Financial Result|Net Profit ICCM|Net Income pulmonx.com LUNG|Net Profit TELA (TELA Bio)|Net Profit CytoSorbents Corp CTSO|SRTS - Company Net Income|ZYXI: Company Net Income|ECOR (electrocore.com) - Net Income|Vicarious Surgical - Final Profit|IINN (Inspira Technologies Oxy B.H.N. Ltd.) - Net Profit|Company Net Income seastarmedical.com ICU|Company Net Income IRIDEX Corporation (IRIX)|ibs.inc (INBS) - Annual Net Income|Beyond Air - Net Income|Net Profit Profusa, Inc PFSA|STRATA Skin - Net Profit|Net Financial Result GlucoTrack Inc. GCTK|NanoVibronix, Inc. (NAOV) - Company Net Income|Profit After Tax NUWE (Nuwellis Inc)|Company Net Income Aethlon|Net Income TransEnterix (ASXC)|Net Profit AVGR|BSGM - Company Net Income|Company Net Income Cutera CUTR|KNW: Company Profit|NARI: Net Income|Nevro Medical - Profit After Payment of Taxes|RSLS (reshapelifesciences.com) - Net Income|SILK (silkroadmed.com) - Company Net Income